Agoracom Blog Home

Posts Tagged ‘#smallcapstocks’

« Older Entries
Newer Entries »

Gaming for a living? It’s a real thing $GMBL.us

Posted by AGORACOM-JC at 9:35 AM on Monday, April 10th, 2017
  • Call of Duty: Infinite Warfare was the challenge with $10,000 at stake as teams of four went head-to-head to work their way up the bracket
  • Infinite Warfare was the challenge with $10,000 at stake as teams of four went head-to-head to work their way up the bracket

For two days this past weekend, local video game aficionados were invited to bring their A-game to the Machine Shop for the first ever Sault Ste. Marie UMG Pro-Am tournament. Call of Duty: Infinite Warfare was the challenge with $10,000 at stake as teams of four went head-to-head to work their way up the bracket. The entire eSports event was broadcast on Twitch.tv and Microsoft’s new streaming platform, Beam.

“A lot of people identify video game tournaments with where they came from – college dormitories and things like that. Around 2010, we got the ability to broadcast tournaments and that’s really what’s made eSports the billion dollar industry that it is,” explained Cynn Smith, event lead at UMG. “In many way we emulate traditional sports – we have analysts, we have commentators, we have massive production needs.”

The world of eSports has grown very quickly, Smith said, and the players responsible for that surge are now gaming as professionals. While traditional sports recruit new talent from college, eSports recruitment is a bit more challenging.

“It’s actually rare for new teams to show up,” he said. “We’re looking at places like Sault Ste. Marie, and other places in Canada and around the world where we can find that new talent – getting them on stage, getting them on camera – so they can be noticed. We see ourselves as a stepping stone for their career just as much as a provider for entertainment.”

And gaming can definitely lead to a career. Upper echelon eSports teams can make a living at it, Smith said, but not from tournament prize money. The real money comes by way of corporate sponsorships.

“That’s way we keep our production and broadcast quality high,” he said. “We’re making these amateurs look like professionals, and that’s going to be the number one thing they need to get sponsors and to go full time. There’s a lot of teams that can and do this full time.”

While the majority of participating teams in the Sault Ste. Marie UMG Pro-Am tournament were local, a few traveled from out of town for the event including the reigning COD world champion SetToDestroyX. The Canadian team managed to live up to its title, taking home first place and $6,000 of the prize pool. 1 Hype placed second followed by PrimeTime Nation in third.

Source: https://www.sootoday.com/local-news/gaming-for-a-living-thats-a-thing-7-photos-584514

Tags: , , , , , ,
Posted in VGambling Inc. | Comments Off on Gaming for a living? It’s a real thing $GMBL.us

Tetra Bio-Pharma Upgrades to OTCQB to Engage and Expand U.S. Investor Audience $TBP.ca

Posted by AGORACOM-JC at 4:44 PM on Wednesday, April 5th, 2017

Tbp large

  • Announced that effective tomorrow, shares of the Company have been approved for and will commence trading on the OTCQB venture marketplace
  • Ticker symbol GRPOF

OTTAWA, ONTARIO–(April 5, 2017) – Tetra Bio-Pharma Inc. (“Tetra“) (CSE:TBP)(CSE:TBP.CN)(OTCQB:GRPOF), today announced that effective tomorrow, shares of the Company have been approved for and will commence trading on the OTCQB venture marketplace, operated by OTC Markets Group, under the ticker symbol GRPOF. Shares of the Company previously traded on the OTCQI Pink Sheet Market. The Company also reiterated its strategy to create greater opportunity for its shareholders and attract new U.S. retail and institutional investors by providing transparency via this up-listing.

“We are extremely pleased to announce our up-list to the OTCQB Venture Marketplace,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “Tetra is committed to the high level of financial and corporate disclosure that is required for this listing category which further demonstrates significant improvement in how we are categorized in the public markets. This move represents our expansion in growing our U.S. investor shareholder base as we believe that trading on the OTCQB will enhance trading liquidity and continue to increase market adoption of our business model, thereby enhancing shareholder value. We look forward to aggressively executing our business plan as we build a leading bio-pharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs.”

The OTCQB is considered by the SEC as an established public market for the purpose of determining the public market price when registering securities for resale with the SEC. The OTCQB dramatically increases transparency, reporting standards, management certification and compliance requirements, the majority of broker dealers trade stocks on the OTCQB. Historically this has resulted in greater liquidity and awareness for companies that reach the OTCQB tier.

McMillan LLP serves as Tetra’s OTCQB advisor, responsible for providing professional guidance on OTCQB requirements and U.S. securities laws. U.S. investors can find current financial disclosure and quotes for the company on www.otcmarkets.com.

About Tetra Bio Pharma:

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP)(CSE:TBP.CN)(OTCQX:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
(343) 689-0714
[email protected]
www.tetrabiopharma.com

Tags: ,
Posted in Medical Marijuana Stocks, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma Upgrades to OTCQB to Engage and Expand U.S. Investor Audience $TBP.ca

Health Canada urged to clear the way for medical pot insurance $TBP.ca

Posted by AGORACOM-JC at 11:07 AM on Wednesday, April 5th, 2017

Medical marijuana advocates in Alberta say Ottawa needs to expedite safety approvals that would allow insurance companies to provide coverage for costly prescriptions.

  • As the federal government prepares to legalize recreational marijuana by July 2018, Grindle is among the advocates calling on Health Canada  to clear the way for coverage of legally-prescribed pot.

Medical marijuana advocates in Alberta say Ottawa needs to expedite safety approvals that would allow insurance companies to provide coverage for costly prescriptions. (CBC)

Related Stories

Conventional pills did little to ease Jill Grindle’s PTSD and sleep disorder, but within months of turning to medical marijuana the Calgary mother says she was sleeping through the night.

Now she has another worry.

“It’s costing a pretty penny,” she said. “So what I do is I under-medicate greatly. I scrimp and I save and I only use it very sparingly.”

Like most Canadians, Grindle’s standard insurance plan doesn’t cover legally prescribed cannabis. For Grindle that adds up to $1,200 a month if she were to use her full four-gram daily allowance, so she gets by on one gram a day.

As the federal government prepares to legalize recreational marijuana by July 2018, Grindle is among the advocates calling on Health Canada  to clear the way for coverage of legally-prescribed pot.

With the exception of limited coverage for veterans and patients with health care spending accounts, the standard insurance of most Canadians doesn’t reimburse the cost of medical cannabis.

Kait Shane, director of community outreach with Calgary-based Natural Health Services, describes it as the “missing link,” noting Canadians can claim cannabis on their their tax returns and travel with it on federal flights.

“Every patient comes in and is kind of wondering the same thing. Can we be covered; will we be covered?” said Shane, whose Calgary-based company prescribes cannabis at several western locations including Edmonton.

She said the problem is that medical marijuana doesn’t have a drug identification number (DIN); a classification that requires going through a rigorous, expensive approval process required of all new drugs.

Kait Shane with Natural Health Services says out-of-reach cannabis prices push some patients to illegal sources.

“It’s a matter of lobbying … to get Health Canada to recognize it’s not feasible for them to go through the same trials as other drugs,” said Shane, who points out that unlike other narcotics, cannabis has been used for a long time.

Shane worries not insuring medical cannabis will alienate those who can’t afford to get it through licensed producers.

“High costs currently push many patients to seek alternative options through illegal avenues with zero testing protocols,” she said. “The lack of testing could put a patient’s health at risk.”

Joan Weir, director of health police at the Canadian Life and Health Insurance Association, said the process is moving slowly, despite some employers adding coverage.

“There’s not a lot of good research on the impact of adding medical marijuana to your drug program,” said Weir. “So there needs to be a fair bit more research to make employers comfortable on including it as a benefit.”

Health Canada wasn’t immediately available for comment.

Source: http://www.cbc.ca/news/canada/edmonton/health-canada-urged-to-clear-way-for-medical-pot-insurance-1.4053888

Tags: , , ,
Posted in All Recent Posts, Medical Marijuana Stocks, Tetra Bio-Pharma Inc. | Comments Off on Health Canada urged to clear the way for medical pot insurance $TBP.ca

INTERVIEW: Monarques Gold discusses Gold Bug results of 17.1 g/t Au over 5.9 metres $MQR.ca

Posted by AGORACOM-JC at 9:15 AM on Wednesday, April 5th, 2017

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Monarques Gold | Comments Off on INTERVIEW: Monarques Gold discusses Gold Bug results of 17.1 g/t Au over 5.9 metres $MQR.ca

American Creek Provides Update on Joint Venture Partner Tudor Gold’s Treaty Creek Project Progress $AMK.ca

Posted by AGORACOM-JC at 9:13 AM on Wednesday, April 5th, 2017

Hublogolarge2 copy

  • Provided update outlining the significant progress and future 2017 plans at the Treaty Creek JV Project located in BC’s “Golden Triangle” immediately north of Seabridge Gold’s KSM project and in the same region as Pretivm’s Brucejack project

CARDSTON, ALBERTA–(April 5, 2017) – American Creek Resources Ltd. (TSX VENTURE:AMK) (“American Creek”) is pleased to report that operator Tudor Gold Corp. (“Tudor”) has provided an update outlining the significant progress and future 2017 plans at the Treaty Creek JV Project located in BC’s “Golden Triangle” immediately north of Seabridge Gold’s KSM project and in the same region as Pretivm’s Brucejack project.

Tudor, in yesterday’s news release, provided background, summarized 2016 exploration progress and developments, and outlined the main goals for the 2017 Treaty Creek program (click here for Tudor news release).

Significant achievements in 2016 included:

  1. Successfully conducting an MT survey over a large portion of the property utilizing the exact same technology (and same geophysicist) that was key to the discovery of Seabridge’s several deposits located immediately to the south of the Treaty Creek property.
  2. Significantly expanding the known gold zone around American Creek’s previous Copper Belle discovery hole.

Regarding the success of the MT survey, Tudor included the following in their news release:

The current understanding of the model generated by the 2016 MT survey suggests these things:

  1. The geology underlying the encouraging assays generated by the 2007, 2009, and 2016 drilling in the Copper Belle zone extends over a larger area than has yet been tested through diamond-drilling. The survey suggests the mineralization in the Copper Belle zone might extend for as much as seven hundred meters in the near-surface zone (less than 600 m depth), at it might extend for up to one kilometer at greater depths,
  2. The geology underlying the encouraging assays generated by the 2007 and 2009 drilling in the GR2 zone extends over a larger area than has yet been tested through diamond-drilling and might extend for several hundred meters,
  3. The geology underlying the encouraging assays generated by the 2007, 2009, and 2016 drilling in the Copper Belle zone extends towards the Seabridge Gold Iron Cap deposit.

Regarding Tudor’s 2017 Treaty Creek exploration goals, Tudor included the following in their news release:

  1. Carry out diamond drilling in the Copper Belle zone to both the south and north of prior drilling with the goal of developing a preliminary resource estimate for a low-grade bulk deposit along a strike length of approximately 1000 m,
  2. Carry out diamond drilling in the GR2 zone with the goal of determining how much further drilling or other exploration is required to develop a preliminary resource estimate for that zone, and
  3. Carry out diamond drilling to confirm that the mineralization in the Copper Belle zone extends towards the adjacent Seabridge Gold Inc. Iron Cap deposit.

The precise details of how these drilling programs will be carried out are still being developed.

In addition to these drilling programs, Tudor Gold is also considering further exploration work in the Konkin Gold zone where early exploration produced grab samples, chip samples and trenching samples carrying in excess of 28 ounces of gold per tonne (these historical results are taken from a 1987 Assessment Report submitted to the provincial government by Mr. Cremonese, P. Eng., president of Teuton Resources Corp.; these historical results have not been independently verified by Tudor Gold). Tudor Gold is of the view that further exploration work will be beneficial in understanding the geology and mineralization of the Konkin Gold zone.

Darren Blaney, President and CEO of American Creek stated: “Tudor’s 2016 work at Treaty was a great success and really sets the stage for future advancement including Tudor’s stated goal of developing a Copper Belle preliminary resource estimate in 2017. We are excited about the plans being formulated for the upcoming season. Further adding to the excitement is Seabridge Gold’s plan to conduct an extensive drill program on the Deep Iron Cap zone following up on their spectacular drill hole IC-16-62 from last summer. The Iron Cap is within 1 km of the claim boundary of the Treaty Creek property.”

The Treaty Creek Project is a joint venture between Tudor, Teuton Resources Corp., and American Creek. Tudor is the operator and holds a 60% interest with both American Creek and Teuton each holding respective 20% carried interests in the property (fully carried until a production notice is given).

About American Creek

American Creek holds a strong portfolio of gold and silver properties in British Columbia. The portfolio includes three “Golden Triangle” gold/silver properties; the Treaty Creek and Electrum joint ventures with Tudor as well as the 100% owned past producing Dunwell Mine. Other properties held throughout BC include the Gold Hill, Austruck-Bonanza, Ample Goldmax, Silver Side, Red Tusk and Glitter King.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Kelvin Burton
403-752-4040
[email protected]
www.americancreek.com

Tags: , , , ,
Posted in American Creek Resources Ltd., Featured | Comments Off on American Creek Provides Update on Joint Venture Partner Tudor Gold’s Treaty Creek Project Progress $AMK.ca

Durango Seeks CFIA Certification for Limestone as Fertilizer $DGO.ca

Posted by AGORACOM-JC at 8:00 AM on Wednesday, April 5th, 2017

Logo

  • Management has initiated discussions with the Canadian Food Inspection Agency (CFIA) in relation to using its limestone for fertilizer use

Vancouver, BC / April 5, 2017 – Durango Resources Inc.(TSX.V-DGO) (OTC-ATOXF), (the “Company” or “Durango”) announces that management has initiated discussions with the Canadian Food Inspection Agency (CFIA) in relation to using its limestone for fertilizer use.

Fertilizer and supplement products are regulated under the authority of the Fertilizers Act, which is administered by the CFIA.

Limestone is extremely beneficial for the agricultural industry, as the chemical properties of agricultural lime can significantly boost the profit yield of farms and increase efficiencies of the fertilizers of up to 50%increasing crop yields and profitability.

The limestone is activated when it meets with water and dissolves into the soil, which lowers the acidity and raises the pH, which is essential for crop yields. The lime also adds desirable nutrients to the soils such as calcium, magnesium and phosphorus, which can improve soil structure, increase rates of air and water infiltration, improve plant cell wall formation, and help to regulate the nutrient uptake through the roots of the plant. Hydroponic systems are more prone to incur a calcium deficiency and require the use of limestone, therefore Durango is investigating the synergy of agricultural limestone for such soil conditioning mediums.

Further details on the suitability of Durango’s limestone for use as a fertilizer will be provided as they become available.

About Mayner’s Fortune

The Mayner’s Fortune property is located 7.5 kilometres southwest of Terrace, B.C., along the CN rail route between Terrace and Kitimat and hosts six historically mapped subparallel limestone units. Durango completed two exploration visits on the Mayner’s Fortune project in the late fall of 2016, which included sampling to test limestone quality and mapping substantiate historic reports. Assays results as announced on February 8, 2017 and December 14, 2016 achieved very high calcium carbonate levels.

About Durango

Durango is a natural resources company engaged in the acquisition and exploration of mineral properties. The Company has a 100% interest in the Mayner’s Fortune and Smith Island limestone properties in northwest British Columbia, the Decouverte and Trove gold properties in the Abitibi Region of Quebec, and the NMX East lithium property near the Whabouchi mine and the Buckshot graphite property near the Miller Mine in Quebec, the Whitney Northwest property near the Lake Shore Gold and Goldcorp joint venture in Ontario.

For further information on Durango, please refer to its SEDAR profile at www.sedar.com.

Marcy Kiesman, Chief Executive Officer

Telephone: 604.428.2900 or 604.339.2243

Facsimile: 888.266.3983

Email: [email protected]

Website: www.durangoresourcesinc.com

Forward-Looking Statements

This document may contain or refer to forward-looking information based on current expectations, including, but not limited to obtaining certifications, producing limestone, commencement and completion of future exploration and the impact on the Company of these events. Forward-looking information is subject to significant risks and uncertainties, as actual results may differ materially from forecasted results. Forward-looking information is provided as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances. For a detailed list of risks and uncertainties relating to Durango, please refer to the Company’s prospectus filed on its SEDAR profile at www.sedar.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: , , ,
Posted in Durango Resources | Comments Off on Durango Seeks CFIA Certification for Limestone as Fertilizer $DGO.ca

INTERVIEW: Meet the Namaste Team! $N.ca

Posted by AGORACOM-JC at 5:32 PM on Tuesday, April 4th, 2017

Tags: , , , ,
Posted in AGORACOM Via Satellite, Namaste Technologies Inc. | Comments Off on INTERVIEW: Meet the Namaste Team! $N.ca

Monarques Gold intersects 17.1 g/t Au over 5.9 metres (19.4 feet) on Gold Bug (Croinor Gold) $MQR.ca

Posted by AGORACOM-JC at 2:00 PM on Tuesday, April 4th, 2017

  • Hole CR-17-532 intersected 6.96 g/t Au over 15 metres
  • including 17.1 g/t Au over 5.9 metres
  • Drilling confirms that the shear corridor is mineralized over a width of 15 metres, to a vertical depth of at least 115 metres

MONTREAL, April 4, 2017

Drilling confirms that the shear corridor is mineralized over a width of 15 metres, to a vertical depth of at least 115 metres

MONTREAL, April 4, 2017 – MONARQUES GOLD CORPORATION (“Monarques” or the “Corporation”) (TSX-V: MQR) (FRANKFURT: MR7) is pleased to announce the results of drilling in the Gold Bug area, which lies less than 500 metres from the Croinor Gold deposit.

The 2017 drilling program on Gold Bug was aimed at testing the gold-bearing potential of the zone discovered by the Corporation in January, when Hole CR-16-521 returned an intersection of 8.41 g/t Au over 25 metres (see press release dated January 24, 2017).

Drilling has confirmed that the shear corridor contains anomalous to economic gold grades over a width of about 15 metres, to a vertical depth of at least 115 metres. Hole CR-17-532 intersected 6.96 g/t Au over 15 metres (see plan view), including 17.1 g/t Au over 5.9 metres. That intersection, as well as those from Holes CR-17-526 and CR-17-533, confirms that the shear corridor intersected near surface in Hole CR-16-521 is about 15 metres wide. In addition, Holes CR-17-527 and CR-17-528 returned 0.27 g/t Au over 8.6 metres (from 101.1 to 109.7 metres) and 0.97 g/t Au over 6.7 metres (from 158.1 to 164.8 metres), respectively, demonstrating that the shear corridor extends to a vertical depth of approximately 115 metres. The shear corridor remains open along strike and at depth.

“The results for Gold Bug show increasingly attractive economic gold potential due to the width and depth of the gold-bearing structure discovered in January,” said Jean-Marc Lacoste, President and Chief Executive Officer of Monarques. “We believe that this area could eventually add to the resource for the Croinor Gold project. A key advantage at Gold Bug is that the structure lies close to surface, and could therefore be mined more easily, at a lower cost. This area will remain a high-priority drill target, with further testing of the structure along strike and at depth.”

The following table shows the results for the 2017 drilling program on Gold Bug:

Hole

From (m)

To (m)

Length (m)

Au (g/t)

CR-17-526

   Including

35.8

41.0

51.2

44.2

15.4

3.2

0.69

2.49

CR-17-527

   Including

101.1

101.1

109.7

104.8

8.6

3.7

0.27

0.45

CR-17-528

   Including

158.1

159.5

164.8

161.9

6.7

2.4

0.97

1.73

CR-17-529

166.3

168.3

2.0

0.10

CR-17-530

106.7

107.7

1.0

0.37

CR-17-531

   Including

43.9

49.3

49.8

49.8

5.9

0.5

0.29

2.22

CR-17-532

   Including

21.0

21.0

36.0

26.9

15.0

5.9

6.96

17.07

CR-17-533

   Including

43.3

46.3

61.9

49.5

18.6

3.2

0.63

2.04

 

The widths shown are core lengths; true width cannot be estimated. High grades were cut to 70 g/t, which is the cutoff grade used to calculate the resource estimate for the Croinor Gold deposit.

The technical and scientific content of this press release has been reviewed and approved by Donald Trudel, P.Geo., B.Sc., the Corporation’s Qualified Person under National Instrument 43-101.

Sampling normally consisted of sawing the core into two equal halves along its main axis and shipping one of the halves to the ALS Minerals laboratory in Val-d’Or for assaying. The samples are crushed, pulverized and assayed by fire assay with atomic absorption finish. Results exceeding 3.0 g/t are re-assayed using the gravity method, and samples containing gold grains are assayed using the metallic sieve method. Monarques has established a full QA/QC protocol, including the insertion of standards, blanks and duplicates.

ABOUT MONARQUES GOLD CORPORATION

Monarques Gold is a growing junior gold company focused on becoming the leading explorer and developer of gold properties in the Val-d’Or/Abitibi gold camp in Quebec, Canada. The Corporation currently has approximately 200 km² of gold exploration properties (see map) along the Cadillac Break, as well as its main asset, the Croinor Gold mine, which has great potential to become a producing mine. Monarques Gold is well financed and has close to $9 million in credits from Quebec’s Ministry of Energy and Natural Resources.

(Watch our latest Corporate Video)

Forward-Looking Statements

The forward-looking statements in this press release involve known and unknown risks, uncertainties and other factors that may cause Monarques’ actual results, performance and achievements to be materially different from the results, performance or achievements expressed or implied therein. Neither TSX Venture Exchange nor its Regulation Services. Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

SOURCE Monarques Gold Corporation

 

To view the original version on PR Newswire, visit: http://www.newswire.ca/en/releases/archive/April2017/04/c5950.html

Jean-Marc Lacoste, President and CEO, 1-888-994-4465 x 201, [email protected], www.monarquesgold.comCopyright CNW Group 2017

Unfollow

Tags: , , , ,
Posted in Featured, Monarques Gold | Comments Off on Monarques Gold intersects 17.1 g/t Au over 5.9 metres (19.4 feet) on Gold Bug (Croinor Gold) $MQR.ca

MCOA Finalizes Joint Venture Agreement With Bougainville Ventures in Washington State $MCOA.us

Posted by AGORACOM-JC at 1:16 PM on Tuesday, April 4th, 2017

15233 mcoa

  • Finalized the joint venture agreement with Bougainville Ventures, Inc. in Washington State
  • MCOA will invest $1 million in cash in a newly formed entity
  • Bougainville Ventures, Inc. will contribute its expertise in the construction and management of a 30,000 sq. ft. greenhouse facility

BONSALL, CA–(Apr 4, 2017) – MARIJUANA COMPANY OF AMERICA (“MCOA” or the “Company”) (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution Company, is pleased to announce that it has finalized the joint venture agreement with Bougainville Ventures, Inc. (“BV”) in Washington State.

MCOA will invest $1 million in cash in a newly formed entity. Bougainville Ventures, Inc. will contribute its expertise in the construction and management of a 30,000 sq. ft. greenhouse facility, which will accommodate a Tier-3 production and processing I-502 tenant that has decades of experience and a proven track record of consistency and quality. MCOA and BV will split equity and profits equally, 50/50.

As turnkey landlords, MCOA and BV will provide our I-502 tenant with a state-of-the-art facility that creates an ideal cultivation environment that they can move into and be fully operational on day one. This enables our tenants to focus on what they do best, producing top quality products and not worrying about maintaining their infrastructure.

Donald Steinberg, MCOA President and CEO, said, “This project will help to expand our operations as an ancillary business into the Washington State market. Achieving this milestone of closing this deal, as well as completing our PCAOB audit at the end of the first quarter are two more pillars of the strong foundation we are building for our shareholders.”

The execution of the agreement is the final step in formalizing the Letter of Intent that was publicly announced on February 15, 2017. This joint venture partnership is formed for the purpose of greenhouse construction, management and commercial leasing to I-502 licensed producers within Washington State only and not beyond its borders.

ABOUT BOUGAINILLE VENTURES, INC.

Bougainville Venture Inc. is in the core business of converting irrigated farmland that was traditionally used to grow marginally profitable feed crops, to greenhouse-equipped farmland used to grow luxury crops with a primary focus on high-density and high-yielding crops. Bougainville is an agricultural services company that focuses on providing growers with state-of-the-art computer controlled greenhouses and processing facilities. Bougainville offers fully built out turnkey solutions to tenant-growers and provides growing infrastructure, as well as landlord services for licensed I-502 producers and processors in the state of Washington.

SAFE HARBOR STATEMENT

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

For more information, please visit the Company’s websites at:
MarijuanaCompanyofAmerica.com
hempSMART.com
agoracom.com/ir/MarijuanaCompanyofAmerica

Marijuana Company of America
Investor Relations
1+(888)-777-4362
[email protected]

Tags: , , , ,
Posted in Marijuana Company of America, Medical Marijuana Stocks | Comments Off on MCOA Finalizes Joint Venture Agreement With Bougainville Ventures in Washington State $MCOA.us

Tetra Bio-Pharma and IntelGenx Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet $TBP.ca

Posted by AGORACOM-JC at 8:45 AM on Monday, April 3rd, 2017

Tbp large

  • Signed definitive agreement for the development and commercialization of a drug product containing the cannabinoid Dronabinol
  • for the management of anorexia and cancer chemotherapy-related pain
  • U.S. cancer pain market is expected to reach $5 billion in 2018

OTTAWA, ONTARIO–(April 3, 2017) – Tetra Bio-Pharma Inc. (“Tetra“) (CSE:TBP)(OTC PINK:GRPOF) and IntelGenx Corp. (“IntelGenx”) (TSX VENTURE:IGX)(OTCQX:IGXT), today announced the signing of a definitive agreement for the development and commercialization of a drug product containing the cannabinoid Dronabinol (the “Product”) for the management of anorexia and cancer chemotherapy-related pain. The U.S. cancer pain market is expected to reach $5 billion in 2018. This definitive agreement follows the binding term sheet between the two companies that was announced on February 9, 2017.

Pursuant to the definitive agreement, Tetra has exclusive rights to sell the Product in North America, with a right of first negotiation for territories outside of the United States and Canada. Tetra will make an upfront payment to IntelGenx, in addition to set future milestone and royalty payments, based on the completion of an efficacy study, approvals from the U.S. Food and Drug Association (“FDA”) and Health Canada, and the commercial launch of the Product. IntelGenx will be responsible for the research and development of the Product, including clinical studies, and will develop the product as an oral mucoadhesive tablet based on its proprietary AdVersa® controlled-release technology. Tetra will be responsible for funding the product development, and will own and control all regulatory approvals, including the related applications, and any other marketing authorizations. Tetra will also be responsible for all aspects of commercializing the Product.

“We are pleased to announce the closing of the definitive agreement with IntelGenx and look forward to working very hard with them to bring this much-needed product to patients suffering from cancer pain,” said Andre Rancourt, CEO of Tetra Bio-Pharma Inc. “The execution of this agreement is just the beginning for Tetra as we look forward to aggressively concluding future agreements as we build a leading bio-pharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs.”

“The U.S. cancer pain market is expected to reach $5 billion in 2018, and the quick growing medical cannabis industry is poised to capture a signature portion of that opportunity,” said Dr. Horst G. Zerbe, President and CEO of IntelGenx. “We are pleased to be working with Tetra to bring this much-needed cannabinoid product to North American patients suffering from anorexia and cancer chemotherapy-related pain.”

Background Information: 

There are many clinical problems associated with the use of currently available form of Dronabinol in patients with anorexia and cancer chemotherapy-related pain. It has been demonstrated that psychoactive drugs exert their euphoria, and other psychoactive effects, when the blood levels of the drug rapidly increase. The pharmacokinetic profile of tetrahydrocannabinol (“THC”) and its metabolite increases the abuse potential of cannabinoids like Dronabinol. The significant advantage of an oral mucoadhesive tablet based on IntelGenx’ proprietary AdVersa® controlled-release technology is that it can be adjusted to achieve a predetermined drug release pattern by increasing the residence time, promoting intimate contact with the mucosal tissue and increasing the bioadhesive properties of the dosage form. It is believed that, by deploying this technology in the controlled-release of THC, a longer time release of the drug will be achieved and, thereby, a rapid increase in the blood will be avoided. There will also potentially be improved bioavailability and reduced gastro-intestinal side effects, making a sustained-release THC product a promising alternative in the battle for the reduction of opioids in patients with chronic pain.

About IntelGenx:

IntelGenx is a leading oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX.

IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx state-of-the art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at: www.intelgenx.com.

About Tetra Bio Pharma: 

Tetra Bio Pharma is a multi subsidiary publicly traded company (CSE:TBP) (OTC PINK:GRPOF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

The Canadian Securities Exchange (“CSE”) has not reviewed this news release and does not accept responsibility for its adequacy or accuracy.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a licence for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

Tetra Bio-Pharma Inc.
Edward Miller
Vice President, IR & Corporate Communications
[email protected]
(343) 689-0714
www.tetrabiopharma.com

Tags: , ,
Posted in Featured, Medical Marijuana Stocks, Tetra Bio-Pharma Inc. | Comments Off on Tetra Bio-Pharma and IntelGenx Announce the Signing of a Definitive Agreement for the Development and Commercialization of a Dronabinol XL Tablet $TBP.ca

« Older Entries
Newer Entries »